Wed, Aug 27, 2014, 9:38 AM EDT - U.S. Markets close in 6 hrs 22 mins


% | $
Quotes you view appear here for quick access.

OncoSec Medical Incorporated Message Board

  • daggidoodle daggidoodle Jul 30, 2013 11:18 AM Flag

    positive press today for OncoSec

    Another company that had a positive news release last week was OncoSec Medical (OTCMKTS:ONCS). On Monday, July 22, OncoSec presented positive immune response data from its Phase II study at the 8th World Congress of Melanoma. The data showed that ImmunoPulse demonstrated a significant change in tumor immunity following treatment with DNA IL-12 and electroporation. The purpose of ImmunoPulse is to deliver a protein called DNA IL-12, which then stimulates the immune system to target and kill cancer cells. For this particular Phase II trial, there were a total of 25 enrolled patients with either stage III or IV cutaneous and in-transit metastatic melanoma. The trial was designed to determine the body's response after receiving treatment with DNA IL-12 and electroporation with a primary endpoint of 24 weeks. One of the primary and most important results from the trial was a significant decrease in the amount of exhausted T-cells. OncoSec was able to accomplish this by blocking PD-1, which is expressed in activated exhausted T-cells. Additionally, there was a noticeable increase in NK cell frequency and activation. These interim results demonstrate a lot of promise for OncoSec's platform. If the final results turn out to be as strong as or stronger than these interim results, shareholders should begin to see significant share price appreciation given the market for melanoma. Final results should be announced in the next six to nine months.

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • jim.beemer Jul 30, 2013 11:57 AM Flag

      OncoSec is going to hit the biotechnology market by storm. The company's data is rock solid and the stock remains undervalued. OncoSec could jump 1,000% in one year. At this rate, what's the downside? 50%!? Great risk/reward profile

      Sentiment: Strong Buy

      • 1 Reply to jim.beemer
      • smithygene Jul 30, 2013 12:07 PM Flag

        I agree. There really is no downside compared to the company's potential. I am yet to see any bad data. It's hard to explain why the stock has not traded higher. I think ONCS just needs more coverage. Not too many people know about the stock. It's nice to see InvestorHub writing something about them.

        Sentiment: Strong Buy

0.4390.000(0.00%)Aug 26 3:58 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.